Gordon Ralph Corey
#155,451
Most Influential Person Now
Gordon Ralph Corey's AcademicInfluence.com Rankings
Gordon Ralph Coreyphilosophy Degrees
Philosophy
#8779
World Rank
#12223
Historical Rank
Logic
#5797
World Rank
#7236
Historical Rank
Download Badge
Philosophy
Why Is Gordon Ralph Corey Influential?
(Suggest an Edit or Addition)Gordon Ralph Corey's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. (2000) (3324)
- Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. (2009) (1788)
- Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. (2006) (1131)
- Staphylococcus aureus endocarditis: a consequence of medical progress. (2005) (1117)
- Epidemiology of methicillin-resistant Staphylococcus aureus. (2008) (888)
- Extra‐Intestinal Manifestations of Salmonella Infections (1987) (620)
- Clinical identifiers of complicated Staphylococcus aureus bacteremia. (2003) (597)
- Contemporary clinical profile and outcome of prosthetic valve endocarditis. (2007) (556)
- Changing patient characteristics and the effect on mortality in endocarditis. (2002) (513)
- Catheter-Related Bacteremia and Outcome of Attempted Catheter Salvage in Patients Undergoing Hemodialysis (1997) (509)
- Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. (1998) (441)
- Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. (1997) (405)
- Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. (2004) (381)
- Early Predictors of In-Hospital Death in Infective Endocarditis (2004) (378)
- An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis (2013) (376)
- Clinical Predictors of Major Infections After Cardiac Surgery (2005) (340)
- Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. (2004) (332)
- Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. (2007) (327)
- Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. (2005) (310)
- Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. (2013) (308)
- Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. (2009) (293)
- Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. (2011) (292)
- Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms. (2008) (287)
- Methicillin-resistant Staphylococcus aureus: an evolving pathogen. (2014) (287)
- Staphylococcus aureus Bacteremia in Patients With Permanent Pacemakers or Implantable Cardioverter-Defibrillators (2001) (276)
- Cytomegalovirus Infection in the Normal Host (1985) (270)
- Analysis of the Impact of Early Surgery on In-Hospital Mortality of Native Valve Endocarditis: Use of Propensity Score and Instrumental Variable Methods to Adjust for Treatment-Selection Bias (2010) (263)
- Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial. (2014) (260)
- Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. (2001) (255)
- Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. (2005) (244)
- Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study (2011) (241)
- Single-dose oritavancin in the treatment of acute bacterial skin infections. (2014) (238)
- Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. (2010) (233)
- Etiology of large pericardial effusions. (1993) (228)
- Costs and Outcomes Among Hemodialysis-Dependent Patients With Methicillin-Resistant or Methicillin-Susceptible Staphylococcus aureus Bacteremia (2005) (215)
- Early surgery in patients with infective endocarditis: a propensity score analysis. (2007) (210)
- In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. (2013) (201)
- CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. (2010) (201)
- Staphylococcus aureus bloodstream infections: definitions and treatment. (2009) (189)
- The risk of stroke and death in patients with aortic and mitral valve endocarditis. (2001) (187)
- HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort (2013) (185)
- Single and Multiple Pyogenic Liver Abscesses: NATURAL HISTORY, DIAGNOSIS AND TREATMENT, WITH EMPHASIS ON PERCUTANEOUS DRAINAGE (1984) (183)
- Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study. (2015) (179)
- Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. (1999) (178)
- Disseminated infection with rapidly growing mycobacteria. (1993) (177)
- Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia (1999) (176)
- Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria. (2005) (172)
- Assessing housestaff diagnostic skills using a cardiology patient simulator. (1992) (169)
- Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. (2008) (168)
- Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study (2006) (158)
- Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. (1998) (153)
- Clinical Outcomes and Costs Due to Staphylococcus aureus Bacteremia Among Patients Receiving Long-Term Hemodialysis (2005) (152)
- Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. (2007) (152)
- Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. (2005) (150)
- CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. (2010) (146)
- The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. (2005) (146)
- Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. (1999) (145)
- Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery. (2010) (142)
- Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. (2011) (135)
- Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. (2005) (133)
- Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. (2004) (133)
- Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. (2005) (132)
- Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. (2010) (132)
- Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. (2004) (131)
- Resistant Enterococci: A Prospective, Study of Prevalence, Incidence, and Factors Associated With Colonization in a University Hospital (1996) (130)
- Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia (2006) (129)
- Periannular complications in infective endocarditis involving prosthetic aortic valves. (2006) (128)
- Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis (2003) (126)
- International health and internal medicine residency training: the Duke University experience. (1995) (125)
- Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. (2009) (124)
- Repeat infective endocarditis: differentiating relapse from reinfection. (2005) (123)
- Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates (2008) (123)
- Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections (2014) (123)
- Periannular complications in infective endocarditis involving native aortic valves. (2006) (115)
- Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections (2010) (111)
- Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis (2016) (108)
- Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure (2009) (106)
- Negative predictive value of the Duke criteria for infective endocarditis. (1996) (105)
- A meta-analysis of medical versus surgical therapy for Candida endocarditis. (2005) (105)
- Frequency of Infective Endocarditis Among Infants and Children With Staphylococcus aureus Bacteremia (2004) (97)
- Venous thrombosis in patients with short- and long-term central venous catheter–associated Staphylococcus aureus bacteremia* (2008) (96)
- The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints (2001) (90)
- Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis (2004) (89)
- Cranial computed tomography before lumbar puncture: a prospective clinical evaluation. (1999) (88)
- Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. (2015) (87)
- Coagulase-negative staphylococcal prosthetic valve endocarditis—a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study (2008) (86)
- Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database. (1998) (86)
- Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. (1998) (83)
- Life-threatening Cache Valley virus infection. (1997) (82)
- Associations between the Genotypes of Staphylococcus aureus Bloodstream Isolates and Clinical Characteristics and Outcomes of Bacteremic Patients (2008) (79)
- Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria. (2000) (76)
- The diagnosis of Plasmodium falciparum infection using a new antigen detection system. (1995) (73)
- Rocky Mountain “Spotless” and “Almost Spotless” Fever: A Wolf in Sheep's Clothing (1992) (73)
- Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database (2006) (73)
- In Vitro Resistance to Thrombin-Induced Platelet Microbicidal Protein among Clinical Bacteremic Isolates of Staphylococcus aureus Correlates with an Endovascular Infectious Source (1998) (71)
- The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina. (1999) (70)
- Brazilian spotted fever in Espirito Santo, Brazil: description of a focus of infection in a new endemic region. (1993) (68)
- Risk Factors for Infective Endocarditis in Patients with Enterococcal Bacteremia: A Case-Control Study (2004) (68)
- An integrated transcriptome and expressed variant analysis of sepsis survival and death (2014) (65)
- Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. (2005) (65)
- In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. (2000) (64)
- A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study (2014) (64)
- Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database (2005) (64)
- Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia. (2008) (63)
- Tedizolid (TR-701): a new oxazolidinone with enhanced potency (2012) (62)
- Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen type. (2012) (60)
- Postoperative pubic osteomyelitis misdiagnosed as osteitis pubis: report of four cases and review. (1993) (59)
- Etiology , and Outcome of Infective Endocarditis in the 21 st Century The International Collaboration on Endocarditis – Prospective Cohort Study (2009) (57)
- Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. (2000) (57)
- Presence of Genes Encoding the Panton-Valentine Leukocidin Exotoxin Is Not the Primary Determinant of Outcome in Patients with Complicated Skin and Skin Structure Infections Due to Methicillin-Resistant Staphylococcus aureus: Results of a Multinational Trial (2009) (56)
- Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. (2006) (56)
- Mycoplasmal pericarditis: evidence of invasive disease. (1993) (55)
- Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival (2014) (55)
- Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility. (2000) (54)
- Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. (2009) (54)
- An evaluation of the Duke criteria in 25 pathologically confirmed cases of prosthetic valve endocarditis. (1997) (54)
- Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. (2003) (53)
- The use of a polymerase chain reaction as a diagnostic test for Rocky Mountain spotted fever. (1994) (53)
- A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response (2016) (49)
- Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia (2005) (49)
- Cardiac conduction abnormalities in endocarditis defined by the Duke criteria. (2001) (49)
- Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy. (1992) (47)
- Significance of Clostridium tertium bacteremia in neutropenic and nonneutropenic patients: review of 32 cases. (2001) (47)
- Ceftaroline: a cephalosporin with expanded Gram-positive activity. (2009) (46)
- Candida Endocarditis: Contemporary Cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-MD) (2004) (45)
- Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemic. (2011) (45)
- Mycoplasma hominis septic arthritis: two case reports and review. (1994) (45)
- Purulent pericarditis caused by Candida: report of three cases and identification of high-risk populations as an aid to early diagnosis. (1988) (44)
- New treatments for methicillin-resistant Staphylococcus aureus (2009) (44)
- A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections. (2011) (43)
- New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good. (2011) (43)
- Cytomegalovirus pericarditis: a case series and review of the literature. (1995) (43)
- Herpetic whitlow. (1983) (42)
- A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1 (2017) (42)
- Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus (2010) (42)
- Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial (2018) (40)
- Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment. (2004) (40)
- Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections (2007) (40)
- Resident utilization of information technology (2001) (40)
- Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. (2009) (39)
- Correlation between fundamental binding forces and clinical prognosis of Staphylococcus aureus infections of medical implants. (2007) (38)
- Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis (2015) (38)
- Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis (2009) (38)
- Prosthetic joint infection due to Histoplasma capsulatum: case report and review. (1998) (38)
- TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections (2012) (37)
- In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017 (2019) (37)
- Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis (2020) (36)
- Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya. (2015) (36)
- Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group. (2017) (36)
- Staphylococcus aureus meningitis: review of 28 cases. (1989) (34)
- A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study) (2018) (33)
- Incidence of and Preoperative Risk Factors for Staphylococcus aureus Bacteremia and Chest Wound Infection After Cardiac Surgery (2009) (32)
- A Prospective Trial of Subxiphoid Pericardiotomy in the Diagnosis and Treatment of Large Pericardial Effusion A Follow‐Up Report (1993) (31)
- Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies (2014) (31)
- Impact of Cardiac Implantable Electronic Device Infection (2020) (30)
- Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults (2018) (29)
- Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus. (2016) (29)
- Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection. (2018) (28)
- An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective Endocarditis. (2016) (27)
- Potential Role for Telavancin in Bacteremic Infections Due to Gram-Positive Pathogens: Focus on Staphylococcus aureus (2014) (26)
- Rocky Mountain "spotless" and "almost spotless" fever: a wolf in sheep's clothing. (1993) (26)
- Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis (2015) (26)
- Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis. (1999) (25)
- Bacillus cereus necrotizing cellulitis mimicking clostridial myonecrosis: case report and review of the literature. (1997) (24)
- Short-course therapy for bloodstream infections in immunocompetent adults. (2009) (24)
- Staphylococcus aureus bacteremia among patients with health care-associated fever. (2009) (23)
- Exebacase for Staphylococcus aureus bloodstream infection and endocarditis. (2020) (23)
- Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. (2015) (22)
- A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens. (2017) (21)
- Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis. (2007) (21)
- Leptotrichia endocarditis: Report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases (2008) (20)
- Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials (2017) (20)
- Resident Utilization of Information Technology: A Randomized Trial of Clinical Question Formation (2001) (19)
- Consultation in university-based and community-based infectious disease practices: a prospective study. (1995) (19)
- Novel approaches to clinical trials: device-related infections. (2004) (19)
- Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections. (2012) (19)
- New developments in the management of severe skin and deep skin structure infections – focus on tedizolid (2015) (17)
- Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. (2013) (17)
- Clostridium septicum abscess in hepatic metastases: successful medical management. (1994) (16)
- Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia (2011) (16)
- Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections. (2018) (15)
- Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial (2020) (15)
- An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection (2015) (15)
- Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis (2000) (15)
- Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe. (2017) (15)
- Stunned myocardium in the toxic shock syndrome. (1992) (14)
- In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017 (2019) (14)
- Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies (2018) (14)
- Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy. (2009) (13)
- Diagnosis and management (by subxiphoid pericardiotomy) of large pericardial effusions causing cardiac tamponade. (1992) (13)
- Gonococcal osteomyelitis. Case report and review of the literature. (1991) (13)
- Gonococcal Endocarditis: A New Look at an Old Disease (1989) (12)
- Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review. (2012) (12)
- A randomized, blinded, multicenter trial of a gentamicin vancomycin gel (DFA-02) in patients undergoing abdominal surgery. (2017) (12)
- Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies (2012) (12)
- Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial. (2020) (12)
- Imported African tick bite fever: a case report. (1999) (11)
- Risk of intravascular cardiac device infections in patients with bacteraemia: impact on device removal. (2008) (11)
- Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis (2007) (10)
- Introduction: fusidic acid enters the United States. (2011) (10)
- Iclaprim: a differentiated option for the treatment of skin and skin structure infections (2018) (10)
- Oritavancin for acute bacterial skin and skin structure infections (2015) (9)
- Staphylococcus aureus bacteremia (1997) (8)
- Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe. (2019) (7)
- Trimethoprim-sulfamethoxazole vs. ampicillin in the treatment of experimental meningitis due to Streptococcus pneumoniae. (1982) (7)
- A balancing act: microbe versus muscle. (2009) (7)
- Dalbavancin or oritavancin for skin infections. (2014) (7)
- Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance (2015) (6)
- Staphylococcus aureus Bacteremia and Endocarditis: The Role of Diagnostic Evaluation (2011) (6)
- Ceftaroline applications for therapy in the United States. (2012) (6)
- A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies. (2019) (6)
- Arsenic poisoning seen at Duke Hospital, 1965-1998. (1999) (6)
- Echocardiography for the diagnosis of Staphylococcus aureus infective endocarditis (1999) (6)
- Ceftaroline for complicated skin and skin-structure infections (2010) (6)
- P847 Activity of telavancin against Staphylococcus aureus isolates carrying the Panton-Valentine leukocidin gene in the ATLAS studies (2007) (5)
- Staphylococcus aureus bacteremia in patients with neutropenia. (2002) (5)
- Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection. (1999) (5)
- Rhodococcus equi endocarditis in immunocompetent hosts: report of the first two cases. (2009) (5)
- Telavancin's interactions with the bacterial cell membrane. (2010) (5)
- Medical treatment of endocarditis (2007) (4)
- P845 ATLAS 1: the first Phase 3 study evaluating the new lipoglycopeptide, telavancin, for the treatment of patients with complicated skin and skin structure infections (2007) (4)
- Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival (2014) (4)
- Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates (2016) (4)
- Dual infection with Ehrlichia chaffeensis and a spotted fever group rickettsia: a case report. (1998) (3)
- Thirty Operating Rules for Infectious Diseases Apprentices (2007) (3)
- Assessment of telavancin minimal inhibitory concentrations by revised broth microdilution method in phase 3 complicated skin and skin-structure infection clinical trial isolates. (2017) (3)
- Cutaneous cholesterol embolism of the lower extremities. (1983) (3)
- Treating Sternal Wound Infections After Cardiac Surgery With an Implantable Gentamicin-Collagen Sponge—Reply (2010) (3)
- The significance of elevated troponin T in patients with nondialysis‐dependent renal insufficiency: A validation with coronary angiography (2005) (3)
- Successful laparoscopic management of perforated gallbladder associated with Salmonella javiana infection. (1992) (3)
- A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections. (2020) (3)
- Diagnostic dilemma in a returning traveler with fever. (2013) (3)
- A randomized, double-blind, placebo controlled safety, tolerability, and pharmacokinetic dose escalation study of a gentamicin vancomycin gel in patients undergoing colorectal surgery (2016) (3)
- Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials. (2019) (3)
- NOSOCOMIAL FEVER OF UNKNOWN ORIGIN (1999) (3)
- A Key Miscommunication (2008) (2)
- P846 ATLAS 2: a double-blind, randomised, active controlled, multinational Phase 3 study comparing telavancin with vancomycin for the treatment of patients with complicated skin and skin structure infections (2007) (2)
- An intracardiac mass in a young man with congenitally acquired HIV. (2004) (2)
- The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogens. (2018) (2)
- SINGLE AND MULTIPLE PYOGENIC ABSCESSES (1984) (2)
- Reply to Shah (2005) (2)
- Positive and negative effects of transesophageal echocardiography on the duke criteria for infective endocarditis (1996) (2)
- Use of the Duke criteria for the diagnosis of infective endocarditis. (1995) (2)
- 1261Geographical variations in the incidence of CIED infection and infection prevention strategies: Update from the global WRAP-IT study (2020) (1)
- Reply to Solnick. (2015) (1)
- Not so good to the last drop. Ethylene glycol poisoning in a coffee-consuming camper. (1992) (1)
- Outcome of Staphylococcus aureus Bacteremia according to compliance with infectious diseases specialist recommendations (1997) (1)
- Comparison of Safety Profile of Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ) in theTreatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Integrated Safety Findings from Two Phase III Studies (2017) (1)
- A painful swollen arm in a young woman. (1983) (1)
- Distended neck veins. (1983) (1)
- 1171-206 Frequency of infective endocarditis among infants and children with staphylococcus aureus bacteremia (2004) (1)
- Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012) (2023) (1)
- Delafloxacin in Acute Bacterial Skin and Skin Structure Infections (2019) (1)
- A Phase II Randomized , Double-blind , Multicenter Study to Evaluate Ef fi cacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Con fi rmed to be Due to Gram-positive Pathogens (2017) (1)
- 252 Efficacy Outcomes by Lesion Type in Studies of a Single Dose of Oritavancin Compared to 7 to 10 Days of Vancomycin (2014) (1)
- Staphylococcus aureus bacteremia: A treatment algorithm (1997) (1)
- Venomous Snake Bites (2012) (1)
- BAC DOOR: A Clinician Ranking Exercise for Better Staphylococcus aureus Bacteremia Trial Design (2016) (1)
- Angiokeratoma of Fordyce. (1990) (1)
- Chronic fatigue syndrome. A practical approach. (1992) (1)
- Of hogs and men. Does North Carolina's hog industry raise the risk of infectious disease? (1998) (1)
- 849. Reduced CIED Infections with an Antibacterial Envelope: Microbiologic Analysis of the WRAP-IT Study (2019) (1)
- Treatment-Selection Bias Endocarditis : Use of Propensity Score and Instrumental Variable Methods to Adjust for Analysis of the Impact of Early Surgery on In-Hospital Mortality of Native Valve (2010) (0)
- 1143-136 Prosthetic valve endocarditis: Report of 214 cases from the intracardiac echocardiography prospective cohort study (2004) (0)
- USE OF MACHINE LEARNING TECHNIQUES TO IDENTIFY RISK FACTORS FOR CARDIAC IMPLANTABLE ELECTRONIC DEVICE (CIED) INFECTION: LESSONS FROM THE WRAP-IT TRIAL (2020) (0)
- Pericarditis Due to Mycobacterium avium-intracellulare in an Immunocompetent Host (1996) (0)
- Cardiac tamponade: Clinical features and management by subxiphoid pericardiotomy (1991) (0)
- A closer inspection of tedizolid - authors' reply. (2015) (0)
- 1338. A Pooled Analysis of Patients With Wound Infections in the Phase 3 REVIVE Trials: Randomized, Double-blind Studies to EValuate the Safety and Efficacy of Iclaprim Vs. Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure Infections (2018) (0)
- Abstract 3452: The Significance of Health Care-Associated Infection in Prosthetic Valve Infective Endocarditis (2006) (0)
- 868-2 Cardiovascular risk factors and outcomes in patients with definite endocarditis: The international collaboration on endocarditis - prospective cohort study (2004) (0)
- Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia (2017) (0)
- Pericardial pseudoeffusion due to steroid-induced lipomatosis. (1985) (0)
- BACTEREMIC HOSPITAL-ACQUIRED PNEUMONIA CASES FROM THE ATTAIN STUDIES (2009) (0)
- An integrated transcriptome and expressed variant analysis of sepsis survival and death (2014) (0)
- 2289. Bacterial Causes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Patients with Intravenous Drug Use (IVDU): Phase 3 REVIVE Studies (2019) (0)
- Acute bacterial sinusitis. (1986) (0)
- Klebsiella pneumoniae Liver Abscess , Endophthalmitis , and Meningitis in a Man with Newly Recognized Diabetes Mellitus (2010) (0)
- Morphology of Anorexigen-Associated Valve Disease by Transthoracic and Transesophageal Echocardiography (2002) (0)
- Tofacitinib versus Methotrexate in Rheumatoid Arthritis (2014) (0)
- A chronically red eye. (1983) (0)
- P75 OUTCOME OF EARLY VALVE SURGERY COMPARED TO MEDICAL TREATMENT IN INFECTIVE ENDOCARDITIS COMPLICATED WITH EMBOLIC STROKE (2013) (0)
- Comparison of Staphylococcus lugdunensis and staphylococcus epidermidis native valve endocarditis from the International Collaboration on Endocarditis - Prospective cohort study (2007) (0)
- Infective endocarditis 9 questions physicians often ask (2006) (0)
- Abstract 3453: Regional Variation in the Presentation and Outcome of Patients with Infective Endocarditis (IE): The International Collaboration on Endocarditis-Prospective Cohort Study (2006) (0)
- Infective endocarditis : Prévention, diagnosis, and treatment (2005) (0)
- Chapter 46 – Myocarditis and pericarditis (2010) (0)
- Dalbavancin or Oritavancin for Skin Infections REPLY (2014) (0)
- An “outbreak” of mekongi-species schistosomiasis in central North Carolina (1998) (0)
- Late appearance of skin rash in Rocky Mountain spotted fever. (1983) (0)
- Reply to DiNubile. (2015) (0)
- P844 The ATLAS studies:double-blind, randomised, active controlled, multinational Phase 3 trials comparing telavancin with vancomycin for the treatment of complicated skin and skin structure infections (2007) (0)
- Reply to Bruss (2009) (0)
- 50 – Myocarditis and Pericarditis (2017) (0)
- Chapter 19. Skin and soft tissue infections. (2009) (0)
- Editorial commentary: NOVA score to predict endocarditis in patients with enterococcal bacteremia: sticking to valves or to scores? (2015) (0)
- Reply to Spellberg (2011) (0)
- A returning traveler with fever and rash. (2005) (0)
- Evaluation of Patient Reported outcomes (Pro) In Obese Patients In an acute Bacterial skin and skin Structure Infections (Absssi) Phase 3 trial (2015) (0)
- Reply to Tarchini (2011) (0)
- 99 A Single Dose of Oritavancin Compared to 7 to 10 Days of Vancomycin: Lesion Size Reduction in Phase 3 Studies of Acute Bacterial Skin and Skin Infections (2014) (0)
- A 2012-2014 Global Antimicrobial Surveillance of Iclaprim Against Clinical Strains Causing Hospital-Associated Bacterial Pneumonia (HABP) and Skin and Skin Structure Infections (SSSI) (2016) (0)
- Clinical problem-solving. A key miscommunication--an 81-year-old woman presented to the emergency department with increasing abdominal distention, nausea, and vomiting. (2008) (0)
- A look at the stool can save a barium study. (1983) (0)
- Analysis of CAMERA-1 S. aureus Bacteremia Trial Results using the DOOR (2017) (0)
- O143 Baseline characteristics of patients, with or without MRSA, in two double-blind, randomised, multinational, Phase 3 studies comparing telavancin with vancomycin for the treatment of complicated skin and skin structure infections (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gordon Ralph Corey?
Gordon Ralph Corey is affiliated with the following schools:
